5th edition Bioproduction Congress
"Integrated Continuous vs Classical Manufacturing: pros and cons"
This event will bring together experts from companies (big pharmas, SME and Startups) and laboratories developing therapeutic candidates as well as leading bioproduction professionals to accelerate therapeutics drugs such as mAbs, vaccines, cell therapy and novel products into commercial manufacturing.
Why should you take part?
Call for Abstracts
Submit your abstract to present your project or innovation during the Breakthrough Innovation Session that will be held on September 29th 2019.
Contact : email@example.com